Even though the fold change of BCAS4 was less than the other three up-regulated proteins (periostin, ATAD2, and Ki-67), it was still attractive because BCAS4 was significantly increased in breast tumors compared to normal tumors reported by UALCAN. This evidence concerns the gene BCAS4 and breast neoplasm.